These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

830 related items for PubMed ID: 23378463

  • 1. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [Abstract] [Full Text] [Related]

  • 2. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y, Kondo H, Takeuchi T.
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [Abstract] [Full Text] [Related]

  • 3. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [Abstract] [Full Text] [Related]

  • 4. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
    Pincus T, Furer V, Keystone E, Yazici Y, Bergman MJ, Luijtens K.
    Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1142-9. PubMed ID: 21485024
    [Abstract] [Full Text] [Related]

  • 5. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T.
    Bull NYU Hosp Jt Dis; 2009 Aug; 67(3):254-66. PubMed ID: 19852747
    [Abstract] [Full Text] [Related]

  • 6. Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.
    Rintelen B, Sautner J, Haindl P, Mai H, Brezinschek HP, Leeb BF.
    J Rheumatol; 2013 Apr; 40(4):394-400. PubMed ID: 23378466
    [Abstract] [Full Text] [Related]

  • 7. Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes--advantages of using RAPID3/MDHAQ in routine care.
    Castrejón I, Pincus T.
    Bull Hosp Jt Dis (2013); 2014 Apr; 72(2):136-41. PubMed ID: 25150340
    [Abstract] [Full Text] [Related]

  • 8. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [Abstract] [Full Text] [Related]

  • 9. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN, Bergman MJ, Yourish J, Pei J, Reiss W, Keystone E.
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [Abstract] [Full Text] [Related]

  • 10. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T, Swearingen CJ, Bergman M, Yazici Y.
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [Abstract] [Full Text] [Related]

  • 11. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
    Castrejón I, Dougados M, Combe B, Fautrel B, Guillemin F, Pincus T.
    J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H, Gupta V, Ray S, Kumar H, Talapatra P, Kaur M, Kumar S, Arya S, Mathur R, Ghangas N.
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [Abstract] [Full Text] [Related]

  • 13. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
    Pincus T, Hines P, Bergman MJ, Yazici Y, Rosenblatt LC, MacLean R.
    J Rheumatol; 2011 Dec; 38(12):2565-71. PubMed ID: 22089467
    [Abstract] [Full Text] [Related]

  • 14. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T, Yazici Y, Bergman MJ.
    Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
    [Abstract] [Full Text] [Related]

  • 15. Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria.
    Kuriya B, Sun Y, Boire G, Haraoui B, Hitchon C, Pope JE, Thorne JC, Keystone EC, Bykerk VP, Canadian Early Arthritis Cohort Study.
    J Rheumatol; 2012 Jun; 39(6):1155-8. PubMed ID: 22505708
    [Abstract] [Full Text] [Related]

  • 16. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S, Priyanka BU.
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [Abstract] [Full Text] [Related]

  • 17. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
    Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R.
    Rheumatology (Oxford); 2008 Mar; 47(3):345-9. PubMed ID: 18238788
    [Abstract] [Full Text] [Related]

  • 18. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
    Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM, Siegel EL, Yazici Y.
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL.
    Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
    [Abstract] [Full Text] [Related]

  • 20. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
    Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH.
    Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.